Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Open accessAbstract
To explore the role of cyclooxygenase (COX) in endothelial cell migration and angiogenesis, we have used two in vitro model systems involving coculture of endothelial cells with colon carcinoma cells. COX-2-overexpressing cells produce prostaglandins, proangiogenic factors, and stimulate both endothelial migration and tube formation, while control cells have little activity. The effect is inhibited by antibodies to combinations of angiogenic factors, by NS-398 (a selective COX-2 inhibitor), and by aspirin. NS-398 does not inhibit production of angiogenic factors or angiogenesis induced by COX-2-negative cells. Treatment of endothelial cells with aspirin or a COX-1 antisense oligonucleotide inhibits COX-1 activity/expression and suppresses tube formation. Cyclooxygenase regulates colon carcinoma-induced angiogenesis by two mechanisms: COX-2 can modulate production of angiogenic factors by colon cancer cells, while COX-1 regulates angiogenesis in endothelial cells.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
HIF-1α-induced COX-2 expression leads to elevated PGE2 levels, which can induce PGE2-mediated vascularization.
“HIF-1α-induced COX-2 expression leads to elevated PGE2 levels, which can induce PGE2-mediated vascularization [87,88].”
From The Pathogenesis of Adenomyosis vis-à-vis Endometriosis (2020) · cites this paper as [88]
To ensure that the real-time PCR and Western blot analysis results refer to HESCs but not platelets, the HESCs co-cultured with platelets were washed with sterile PBS three times to remove the platelets.
“To ensure that the real-time PCR and Western blot analysis results refer to HESCs but not platelets, we washed the HESCs that co-cultured with platelets with sterile PBS three times to remove the platelets as reported previously86.”
From Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells (2020) · cites this paper as [86]
Cites
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509 · see citing works
Oshima, M., Dinchuk, J. E., Kargman, S., Oshima, H., Hancock, B. C., Kwong, E. C., Trzăskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,363 · see citing works
Tsujii, M., & DuBois, R. N. (1995) · Cell · doi:10.1016/0092-8674(95)90127-2 · Cited by 2,292 · see citing works
Self-citationCyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398 · see citing works
Self-citationKawamori, T., Rao, C. V., Seibert, K., et al. (1998) · PubMed · Cited by 923 · see citing works
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
Sheng, H., Shao, J., Kirkland, S. C., Isakson, P. C., Coffey, R. J., Morrow, J. D., Beauchamp, R. D., & DuBois, R. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119400 · Cited by 713 · see citing works
Self-citationWarren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., & Ferrara, N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117857 · Cited by 694 · see citing works
Montesano, R., Orci, L., & VASSALLI, P. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.97.5.1648 · Cited by 647 · see citing works
Yang, E. Y., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.731 · Cited by 464 · see citing works
Halting angiogenesis suppresses carcinoma cell invasion
Skobe, M., Rockwell, P., Goldstein, N. I., Vosseler, S., & Fusenig, N. E. (1997) · Nature Medicine · doi:10.1038/nm1197-1222 · Cited by 420 · see citing works
Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs
Smalley, W. E., & DuBois, R. N. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60067-8 · Cited by 358 · see citing works
Self-citationWang, J., Sun, L., Myeroff, L. L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S. D., Willson, J. K. V., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.22044 · Cited by 335 · see citing works
Coffey, R. J., Hawkey, C. J., Damstrup, L., Graves‐Deal, R., Daniel, V. C., Dempsey, P. J., Chinery, R., Kirkland, S. C., DuBois, R. N., Jetton, T. L., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.657 · Cited by 315 · see citing works
Self-citationKoolwijk, P., van Erck, M. G., de Vree, W. J. A., et al. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.132.6.1177 · Cited by 298 · see citing works
Iwasaka, C., Tanaka, K., Abé, M., & Sato, Y. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199612)169:3 · Cited by 278 · see citing works
The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers
Dubois, R. N. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.49 · Cited by 255 · see citing works
Self-citationAspirin use and potential mechanisms for colorectal cancer prevention.
Williams, C. S., Smalley, W., & DuBois, R. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119651 · Cited by 247 · see citing works
Self-citationThe Peroxisome Proliferator‐activated Receptors: Ligands and Activatorsa
FORMAN, B. M., Chen, J., & Evans, R. M. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18621.x · Cited by 218 · see citing works
Perspectives series: cell adhesion in vascular biology. Integrin signaling in vascular biology.
Shattil, S. J., & Ginsberg, M. H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119500 · Cited by 217 · see citing works
Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2
Prescott, S. M., & White, R. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81983-2 · Cited by 198 · see citing works
Shiff, S. J., & Rigas, B. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)99999-6 · Cited by 176 · see citing works
G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2.
DuBois, R. N., Shao, J., Tsujii, M., Sheng, H., & Beauchamp, R. D. (1996) · PubMed · Cited by 172 · see citing works
Self-citationThe role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention
Giardiello, F. M., Offerhaus, G. J. A., & DuBois, R. N. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00137-8 · Cited by 163 · see citing works
Self-citationSankar, S., Mahooti-Brooks, N., Bensen, L., McCarthy, T. L., & Madri, J. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118565 · Cited by 156 · see citing works
Murakami, M., Matsumoto, R., Urade, Y., Austen, K. F., & Arm, J. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3239 · Cited by 148 · see citing works
Functional and molecular aspects of renal prostaglandin receptors.
Breyer, M. D., Jacobson, H. R., & BREYER, R. M. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v718 · Cited by 140 · see citing works
Smith, C. J., Morrow, J. D., Roberts, L. J., & Marnett, L. J. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1483 · Cited by 124 · see citing works
Papapetropoulos, A., Desai, K. M., Rudic, R. D., Mayer, B., Zhang, R., Ruiz‐Torres, M. P., García‐Cardeña, G., Madri, J. A., & Sessa, W. C. (1997) · Europe PMC (PubMed Central) · Cited by 119 · see citing works
Brannon, T. S., North, A. J., Wells, L. B., & Shaul, P. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117220 · Cited by 111 · see citing works
Tumorigenic Transformation of Immortalized ECV Endothelial Cells by Cyclooxygenase-1 Overexpression
Narko, K., Ristimaki, A. P., MacPhee, M. J., Smith, E., Haudenschild, C. C., & Hla, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21455 · Cited by 97 · see citing works
Abé, T., Okamura, K., Ono, M., Kohno, K., Mori, T., Hori, S., & Kuwano, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116599 · Cited by 96 · see citing works
Seed, M. P., Brown, J. R., Freemantle, C. N., et al. (1997) · PubMed · Cited by 81 · see citing works
Differentiation‐associated expression of prostaglandin G/H synthase in monocytic cells
Hoff, T., DeWitt, D. L., Kaever, V., Resch, K., & Goppelt‐Struebe, M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81653-h · Cited by 76 · see citing works
Ueda, N., Yamashita, R., Yamamoto, S., et al. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00131-2 · Cited by 38 · see citing works
Masuda, E., Kawano, S., Nagano, K., et al. (1992) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1992.262.5.g785 · Cited by 23 · see citing works
Self-citationEstablishment of an immortalized Copenhagen rat bone marrow endothelial cell line.
Yamazaki, K., Lehr, J. E., Rhim, J. S., et al. (1996) · PubMed · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
U1 snRNP regulates cancer cell migration and invasion in vitro
Oh, J.-M., Venters, C. C., Di, C., Pinto, A. M., Wan, L., Younis, I., Cai, Z., Arai, C., So, B. R., Duan, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13993-7 · Cited by 7,157 · see citing works
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789 · see citing works
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417 · see citing works
Self-citationInflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312 · see citing works
Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220 · see citing works
Angiogenesis: regulators and clinical applications
Liekens, S., De Clercq, E., & Neyts, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00529-3 · Cited by 748 · see citing works
Recurrence of endometriosis and its control
Guo, S.-W. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp007 · Cited by 719 · see citing works
The urokinase plasminogen activator system: a target for anti-cancer therapy
Ulisse, S., Baldini, E., Sorrenti, S., & D'Armiento, M. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787314002 · Cited by 312 · see citing works
Kaidi, A., Qualtrough, D., Williams, A. C., & Paraskeva, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0425 · Cited by 300 · see citing works
UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression
Bachelor, M. A., & Bowden, G. T. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.017 · Cited by 268 · see citing works
Shimizu, K., Nakata, M., Hirami, Y., Yukawa, T., Maeda, A., & Tanemoto, K. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d60fd7 · Cited by 244 · see citing works
Langenbach, R., Loftin, C., Lee, C., & Tiano, H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00158-6 · Cited by 230 · see citing works
Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb
Silvestre, J.-S., Mallat, Z., Duriez, M., Tamarat, R., Bureau, M. F., Scherman, D., Duverger, N., Branellec, D., Tedgui, A., & Levy, B. I. (2000) · Circulation Research · doi:10.1161/01.res.87.6.448 · Cited by 210 · see citing works
LANGENBACH, R., LOFTIN, C. D., LEE, C., & TIANO, H. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08723.x · Cited by 170 · see citing works
The Pathogenesis of Adenomyosis vis-à-vis Endometriosis
Guo, S.-W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020485 · Cited by 165 · see citing works
A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasation
Lee, H., Park, W., Ryu, H., & Jeon, N. L. (2014) · Biomicrofluidics · doi:10.1063/1.4894595 · Cited by 130 · see citing works
Application of nanoparticles on diagnosis and therapy in gliomas.
Hernández-Pedro, N. Y., Rangel-López, E., Magaña-Maldonado, R., de la Cruz, V. P., Santamaría del Angel, A., Pineda, B., & Sotelo, J. (2013) · BioMed Research International · doi:10.1155/2013/351031 · Cited by 84 · see citing works
Qi, Q., Liu, X., Zhang, Q., & Guo, S.-W. (2020) · Scientific Reports · doi:10.1038/s41598-020-57997-6 · Cited by 44 · see citing works
CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer
Sato-Dahlman, M., Miura, Y., Huang, J. L., Hajeri, P., Jacobsen, K., Davydova, J., & Yamamoto, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18340 · Cited by 43 · see citing works
Cisplatin induces chemoresistance through the PTGS2-mediated anti-apoptosis in gastric cancer
Lin, X.-M., Li, S., Zhou, C., Li, R.-Z., Wang, H., Luo, W., Huang, Y.-S., Chen, L.-K., Cai, J.-L., Wang, T.-X., et al. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105610 · Cited by 43 · see citing works
Qi, Q.-M., Guo, S.-W., & Liu, X.-S. (2019) · Reproductive and Developmental Medicine · doi:10.4103/2096-2924.262390 · Cited by 15 · see citing works
Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer
Guo, X., Oshima, H., Kitmura, T., Taketo, M. M., & Oshima, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800798200 · Cited by 1 · see citing works
- Authors
- Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N.
- Affiliations
- Nashville VA Medical Center (US)
- The University of Osaka (JP)
- Corresponding author
- DuBois, Raymond N
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1998-05
- Volume
- 93
- Issue
- 5
- Pages
- 705-716
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2127558096
- Cited by
- 2,272
- References
- 36
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 15 · 2023: 17 · 2022: 18 · 2021: 32 · 2020: 33 · 2019: 36 · 2018: 21 · 2017: 40 · 2016: 40 · 2015: 47 · 2014: 49 · 2013: 64 · 2012: 63
- FWCI
- 92.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (NIEHS-00267)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK47297)
- Topics
- Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- cyclooxygenase, angiogenesis, colon cancer, cyclooxygenase-2, cyclooxygenase-1, endothelial cell migration, tube formation, prostaglandins, angiogenic factors, NS-398, aspirin
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Antineoplastic Agents, Carcinoma, Cell Communication, Cell Movement, Colonic Neoplasms, Endothelium, Vascular, Growth Substances, Humans, Isoenzymes, Membrane Proteins, Mice, Nude, Molecular Sequence Data, Neoplasms, Experimental, Neovascularization, Pathologic, Prostaglandin-Endoperoxide Synthases, Up-Regulation, Cyclooxygenase Inhibitors, Coculture Techniques, Caco-2 Cells, Mice, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review